GSK Collaborates With Muna To Uncover The Secrets Of Resilient Brains
The big pharma is tapping into Muna’s MiND-MAP platform to gain extra validation for its own early-stage work in Alzheimer’s and other neurodegenerative conditions.
The big pharma is tapping into Muna’s MiND-MAP platform to gain extra validation for its own early-stage work in Alzheimer’s and other neurodegenerative conditions.